Molecular approaches to thyroid cancer diagnosis

SJ Hsiao, YE Nikiforov - Endocrine-related cancer, 2014 - erc.bioscientifica.com
Thyroid nodules are common, and the accurate diagnosis of cancer or benign disease is
important for the effective clinical management of patients. Molecular markers are a helpful …

Poorly differentiated thyroid carcinoma: a clinician's perspective

J Tong, M Ruan, Y Jin, H Fu, L Cheng… - European Thyroid …, 2022 - etj.bioscientifica.com
Poorly differentiated thyroid carcinoma (PDTC) is a rare thyroid carcinoma originating from
follicular epithelial cells. No explicit consensus can be achieved to date due to sparse …

Thyroid cancer stem-like cells: from microenvironmental niches to therapeutic strategies

ES Grassi, V Ghiandai, L Persani - Journal of Clinical Medicine, 2021 - mdpi.com
Thyroid cancer (TC) is the most common endocrine malignancy. Recent progress in thyroid
cancer biology revealed a certain degree of intratumoral heterogeneity, highlighting the …

Poorly differentiated thyroid carcinoma: a retrospective clinicopathological study

GS Cherkaoui, A Guensi, S Taleb, MA Idir… - Pan African Medical …, 2015 - ajol.info
Poorly differentiated thyroid carcinoma (PDTC) is an independent thyroid cancer histotype.
In spite of its scarcity, it represents the main cause of death from non-anaplastic follicular cell …

Poorly differentiated thyroid carcinoma (PDTC) characteristics and the efficacy of radioactive iodine (RAI) therapy as an adjuvant treatment in a tertiary cancer care …

S Thiagarajan, A Yousuf, R Shetty, H Dhar… - European Archives of …, 2020 - Springer
Background Poorly differentiated thyroid cancer (PDTC) is biologically more aggressive.
Surgery remains the mainstay of treatment. The utility of radioactive iodine (RAI) after …

Диагностика новообразований щитовидной железы

ВА Качко, ГВ Семкина, НМ Платонова… - Эндокринная …, 2018 - cyberleninka.ru
В настоящее время во всем мире отмечен существенный рост частоты выявления
узловых новообразований щитовидной железы. Узлы в щитовидной железе в …

Poorly differentiated thyroid carcinoma: 10-year experience in a Southeast Asian population

MG Yu, J Rivera, C Jimeno - Endocrinology and Metabolism, 2017 - synapse.koreamed.org
Background No previous studies have been published on poorly differentiated thyroid
carcinoma (PDTC) in Southeast Asia. Methods We included all adult PDTC patients …

Management of Poorly Differentiated Thyroid Cancer and Differentiated High-Grade Thyroid Carcinoma

IS Alam, KN Patel - Surgical Clinics, 2024 - surgical.theclinics.com
Thyroid carcinoma of follicular cell origin exists on a histopathologic and clinical spectrum.
On one end, up to 87% of thyroid cancers are well-differentiated and have a very favorable …

Association between prognostic factors and clinical outcome of well-differentiated thyroid carcinoma: A retrospective 10-year follow-up study

S Lei, Z Ding, J Ge, D Zhao - Oncology letters, 2015 - spandidos-publications.com
Differentiated thyroid carcinoma (DTC) is one of the most common metabolic disorders and
accounts for 98% of all cases of thyroid cancer. Previously, a number of studies have …

Poorly differentiated thyroid carcinomas: conceptual controversy and clinical impact

A Coca-Pelaz, JP Rodrigo, A Agaimy, MD Williams… - Virchows Archiv, 2024 - Springer
Poorly differentiated thyroid carcinomas (PDTC) are rare diseases; nevertheless, they
account for the majority of deaths from non-anaplastic follicular cell-derived thyroid …